Peptide Adsorption and Recovery: Why Container Surfaces Affect Measurements

Introduction

Anyone who has tried to reconcile a measured peptide concentration with the amount originally weighed in has likely encountered a frustrating phenomenon: part of the peptide simply disappears. One possible explanation is surface adsorption: some peptide has attached to the container rather than remaining in solution. This must be distinguished experimentally from degradation and other sources of loss. Nonspecific adsorption to pipette tips, centrifuge tubes, autosampler vials, and chromatography hardware is a well-documented source of analytical bias in peptide and protein quantification. This article summarizes what analytical chemistry literature reports about the mechanism, the magnitude of the problem, and the mitigation strategies that have been tested at the bench.

It is important to frame the scope correctly from the start: the studies referenced here are bioanalytical method-development papers. They use synthetic peptide mixtures, tryptic digests of model proteins such as bovine serum albumin, or digests derived from cultured HeLa cells as analytical standards. These are laboratory sample-preparation experiments, not cell-based bioactivity assays, animal pharmacokinetic studies, or clinical investigations. The question being asked in this body of work is purely instrumental: how much of a known peptide quantity can be recovered from a container and detected by liquid chromatography–mass spectrometry (LC-MS)?

Why Peptides Stick to Container Walls

Adsorption occurs because peptide surfaces present a patchwork of hydrophobic residues, charged side chains, and polar backbone groups that can interact with a container's surface chemistry. A systematic evaluation using 50 peptides derived from BSA digestion found that adsorption correlated with physicochemical descriptors such as hydrophobicity index and chain length, but the abstract reports limited explanatory power for these descriptors, underscoring that adsorption should not be predicted from sequence properties alone (Nonspecific adsorption evaluation, UPLC-MS, 2022).

A complementary assay designed to characterize surface chemistry directly — rather than peptide chemistry — used a reference mixture of thousands of tryptic peptides to probe different vial types. The authors reported that a substantial number of hydrophobic peptides adsorbed to conventional polypropylene vials, while low-protein-binding polypropylene vials retained far fewer. Glass vials showed the highest overall adsorption, which the authors attributed to electrostatic interactions between peptides and the glass surface (Assay for Characterizing Adsorption-Properties of Surfaces, 2024). This finding is notable because glass is sometimes assumed to be an inert, "safe" choice; the data suggest the opposite can be true depending on the peptide's charge profile.

How Adsorption Distorts Quantification

The practical consequence of surface adsorption is that measured signal no longer tracks linearly with the true concentration of analyte in solution, particularly at low concentrations where a fixed amount of peptide is lost to a fixed amount of surface area. One study modeling LC-MS calibration curves found that adsorption caused calibration curves to behave in a sigmoidal rather than linear fashion at low analyte levels, which is problematic for any protocol that assumes a simple proportional relationship between instrument signal and sample concentration. The same study showed that switching to commercial low-bind microcentrifuge tubes and LC vials, and in some cases adding a second "competitor" protein to occupy adsorption sites, restored a linear response across approximately two to three orders of magnitude, depending on the peptide or protein tested (Improved intact peptide and protein quantitation by LC-MS, 2021).

A related consumable-focused study using HeLa tryptic digest standards reported that preferential adsorption of hydrophobic peptides to polypropylene vials produced nonuniform signal loss — meaning some peptides in a mixture were depleted much more than others. The authors noted this can distort relative quantification approaches such as label-free quantification if no corrective data processing is applied. Switching to vial materials with more polar monomeric units, such as poly(methyl methacrylate) or polyethylene terephthalate, together with the addition of nonionic detergents at optimized low concentrations, substantially reduced peptide loss and improved the number of peptides identified from very low input amounts (Significant impact of consumable material and buffer composition, 2025).

Beyond the Vial: Adsorption Throughout the Workflow

Adsorption is not limited to storage tubes. The UPLC-MS evaluation cited above also tracked carryover across six different chromatographic stationary phases, several mobile-phase gradients, flow rates, and column temperatures, finding that combined optimization of these parameters could reduce residual peptide carryover roughly 150-fold for the most adsorption-prone peptide class tested (Nonspecific adsorption evaluation, UPLC-MS, 2022). A broader review of bioanalytical strategies likewise emphasized that adsorption can occur at essentially every interface an analyte contacts — pipette tips, sample vials, autosampler components, and the chromatography column itself — and that no single universal fix exists because peptide and protein physicochemical diversity is simply too great (Strategies to reduce aspecific adsorption, 2014).

At the extreme end of sample scarcity, single-cell proteomics work illustrates how severe the problem becomes when very little peptide material is present relative to surface area. One approach avoided conventional tube transfers altogether by lysing cells and labeling peptides within a single microhole-collection disc, specifically to prevent the sample losses associated with repeated tube or buffer changes (Zwitterionic detergent single-cell proteomics, 2024). While single-cell proteomics is a different scale of problem than typical peptide handling, it demonstrates the same underlying principle in its most exaggerated form: the smaller the sample, the larger the relative impact of surface adsorption.

Practical Implications for Peptide Research Workflows

Taken together, these analytical studies point toward several consistent, literature-supported considerations for laboratories handling dilute peptide solutions:

• Container material composition can affect recovery. Several studies found advantages for low-binding materials, while the best choice depends on the analyte and experimental conditions.
• Dilute solutions are disproportionately affected because a fixed surface area adsorbs a larger fraction of a small total amount of peptide.
• Adsorption behavior differs peptide by peptide and cannot be fully predicted from sequence properties alone, so empirical testing of a specific peptide-container combination remains the most reliable approach.
• The problem compounds across a workflow — tubes, vials, pipette tips, and chromatography hardware can each contribute independently to total loss.

These considerations are directly relevant to broader topics covered elsewhere, including practical guidance on dissolving and storing research peptides, documentation practices for batch traceability, and the distinct analytical questions answered by HPLC versus LC-MS identity testing.

Evidence Limitations

All findings summarized here are drawn from published abstracts of bioanalytical method-development studies; this article does not represent a full-text review, and methodological details such as exact statistical thresholds, complete experimental conditions, or supplementary data are not assessed. The cited work uses in vitro analytical chemistry systems — synthetic peptide mixtures and protein digests analyzed by LC-MS — rather than cell-based bioactivity assays, animal models, or human/clinical sample handling. Findings on adsorption to polypropylene, glass, or specialty low-bind materials should not be generalized beyond the specific peptides, vial brands, and instrument conditions tested in each study. None of the referenced abstracts describe RCpeptides products, and nothing in this article constitutes guidance on human use, dosing, or treatment; the subject matter concerns laboratory measurement accuracy only.